Navigation Links
NeurogesX Reports Third Quarter 2008 Results
Date:11/6/2008

NeurogesX, Inc.

(A Development Stage Company)

Condensed Consolidated Balance Sheets

(in thousands)

September 30, December 31,

2008 2007

(unaudited) (1)

Assets

Current assets:

Cash and cash equivalents $17,800 $31,478

Short-term investments 13,048 21,373

Prepaid expenses and other current assets 624 585

Total current assets 31,472 53,436

Property and equipment, net 518 453

Restricted cash 240 240

Other assets 24 56

Total assets $32,254 $54,185

Liabilities and Stockholders' Equity

Current liabilities:

Accounts payable $863 $1,712

Accrued compensation 1,009 680

Accrued research and development 1,427 1,198

Other accrued expenses 971 1,848

Notes payable - current portion 3,294 3,859

Total current liabilities 7,564 9,297

Non-current liabilities:

Notes payable - non-current portion 740 3,024

Deferred rent 273 156

Accrued research and development - non-current -- 347

Total non-current liabilities 1,013 3,527

Sto
'/>"/>

SOURCE NeurogesX, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. NeurogesX to Present at BioCenturys NewsMakers in the Biotech Industry Conference
2. NeurogesX Appoints New Director to the Board
3. NeurogesX to Present at UBS 2007 Global Life Sciences Conference
4. NeurogesX Expands Senior Management Team
5. NeurogesX to Present at CIBC World Markets 18th Annual Healthcare Conference and Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
6. NeurogesX to Present at Lazard Capital Markets Healthcare Conference
7. NeurogesX, Inc. Announces $25 Million Private Placement
8. NeurogesX Closes $25 Million Private Placement
9. NeurogesX to Present at the 10th Annual BIO CEO & Investor Conference
10. NeurogesX to Present at Roth 2008 OC Growth Stock Conference
11. NeurogesX to Report Fourth Quarter and Year-End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... new study published today in the journal PNAS ... found that time of day and sleep deprivation have ... be crucial when looking at the best time of ... heart disease, and for administering medicines effectively. , Researchers ... Cancer Research, London, investigated the links between sleep deprivation, ...
(Date:7/10/2014)... the fractional quantum Hall effect in bilayer graphene and ... tuned by an electric field. , The fractional ... to thin sheets are exposed to large magnetic fields, ... of individual electrons behave as a single system. However, ... established, many details of this collective behavior remain not ...
(Date:7/10/2014)... and spiders can sit upside down forever. Nanophysics makes sure ... in an article just published in Physical Review E ... Geckos and spiders that seem to be able to sit ... worldwide for many years. We will soon be able to ... the gecko,s foot. But the fact is, sooner or later ...
(Date:7/10/2014)... at the University of Illinois at Urbana-Champaign provides ... interplay of spin and heat at the nanoscale, ... devices for data storage and information processing. ... spin-angular momentum. In a typical charge current, electrons, ... current," explained David Cahill, a professor of materials ...
Breaking Biology Technology:Time of day crucial to accurately test for diseases, new research finds 2Columbia researchers observe tunable quantum behavior in bilayer graphene 2Columbia researchers observe tunable quantum behavior in bilayer graphene 3Even geckos can lose their grip 2University of Illinois study advances limits for ultrafast nano-devices 2
... ... ... ... ...
... ... ... ... ...
... ... ... ... ...
Cached Biology Technology:Citius Tech Launches BI-Clinical MUSE for Advanced "Meaningful Use" Reporting and Data Submission, and Performance Management for Healthcare ISVs 2Citius Tech Launches BI-Clinical MUSE for Advanced "Meaningful Use" Reporting and Data Submission, and Performance Management for Healthcare ISVs 3Citius Tech Launches BI-Clinical MUSE for Advanced "Meaningful Use" Reporting and Data Submission, and Performance Management for Healthcare ISVs 4Elsevier Addresses Today's Healthcare Information Crisis With a Renewed Focus on Improving Quality and Efficiency 2Elsevier Addresses Today's Healthcare Information Crisis With a Renewed Focus on Improving Quality and Efficiency 3Elsevier Addresses Today's Healthcare Information Crisis With a Renewed Focus on Improving Quality and Efficiency 4Elsevier Addresses Today's Healthcare Information Crisis With a Renewed Focus on Improving Quality and Efficiency 5Elsevier Addresses Today's Healthcare Information Crisis With a Renewed Focus on Improving Quality and Efficiency 6Elsevier Addresses Today's Healthcare Information Crisis With a Renewed Focus on Improving Quality and Efficiency 7Elsevier Addresses Today's Healthcare Information Crisis With a Renewed Focus on Improving Quality and Efficiency 8Elsevier Addresses Today's Healthcare Information Crisis With a Renewed Focus on Improving Quality and Efficiency 9Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 2Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 3Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 4Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 5Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 6Peer-reviewed Articles Further Define Clusterin and the Role of a Clusterin Inhibitor, OGX-011, for the Treatment of Cancer 7
(Date:7/11/2014)... the brains of all vertebrates, information is transmitted ... or chemical signal to be passed from one ... the most abundant type of synapse, can be ... for learning, memory, perception and cognition, and the ... brain function. For instance, every time we ...
(Date:7/10/2014)... YORK , June 27, 2014  Pomerantz ... Provectus Biopharmaceuticals, Inc. ("Provectus" or the "Company")(NYSE-MKT: PVCT) ... filed in United States District Court, Middle District ... is on behalf of a class consisting of ... acquired Provectus securities between December 17, 2013 and ...
(Date:7/10/2014)... , July 2, 2014  Unisys Corporation,s (NYSE: ... Unisys Nederland N.V., today announced that it has been selected ... and manage a new Basic Provision Biometrics solution for penitentiaries ... Unisys won the contract with a solution based on its ... The term of the contract is up to seven years, ...
Breaking Biology News(10 mins):Blame it on the astrocytes 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 2Unisys Delivers New Basic Provision Biometrics Solution to Dutch Custodial Institutions Service 3
... Friday, October 7, 2011, Cleveland: Researchers have ... diseases like asthma, rheumatoid arthritis, psoriasis, inflammatory bowel ... this pathway may provide opportunities for tailored treatments ... of this pathway was the work of an ...
... researchers from the University of Modena and Reggio Emilia ... that in aphids the two X chromosomes have a different ... . Aphids are insects with a sex determination ... in females and a single X chromosome (XO) in males. ...
... Biological invasions, i.e. the spread of introduced, non-native species, ... bring out the importance of economic activities on ecological ... variety of the interaction of economics with invasion science ... problems. Three researchers, lead by Mark Williamson from ...
Cached Biology News:Chromosome inheritance? Not the same for all the chromosomes 2
... Z-Competent E. coli Transformation Buffer Set are ... E. coli cells for simple and highly ... eliminates the requirement for heat shocking and ... be performed by adding DNA to Z-Competent ...
... Universal Amplicon Detection Assay (ADA) ... the qualitative detection and quantitation ... in vitro nucleic acid amplification. ... to be used in diagnostic ...
Propidium Iodide: {3,8-diamino-5-[3-(diethylmethylammonio)propyl]-6-phenylphenanthridinium diodide}. Antifade Solution: p-Phenylenediamine and glycerol in PBS solution. 2.5ug/mL Propidium Iodide (PI)...
Apoptosis Detection Systems and Reagents...
Biology Products: